Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines
Background IMMUNEPOTENT-CRP® (I-CRP) is a bovine dialyzable leukocyte extract containing transfer factor. It is a cost-effective, unspecific active immunotherapy that has been used in patients with non-small cell lung cancer (NSCLC) as an adjuvant to reduce the side-effects of chemotherapy and radio...
Main Authors: | Ana Carolina Martinez-Torres, Luis Gomez-Morales, Alan B. Martinez-Loria, Ashanti Concepcion Uscanga-Palomeque, Jose Manuel Vazquez-Guillen, Cristina Rodriguez-Padilla |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2019-09-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/7759.pdf |
Similar Items
-
IMMUNEPOTENT CRP induces DAMPS release and ROS-dependent autophagosome formation in HeLa and MCF-7 cells
by: Ana Carolina Martínez-Torres, et al.
Published: (2020-07-01) -
IMMUNEPOTENT CRP induces cell cycle arrest and caspase-independent regulated cell death in HeLa cells through reactive oxygen species production
by: Ana Carolina Martínez-Torres, et al.
Published: (2018-01-01) -
Oncogenic RAS mutants confer resistance of rhabdomyosarcoma cells to oxidative stress-induced ferroptotic cell death
by: Christina eSchott, et al.
Published: (2015-06-01) -
Targeting Autophagy Augments BBR-Mediated Cell Death in Human Hepatoma Cells Harboring Hepatitis C Virus RNA
by: Chen-Jei Tai, et al.
Published: (2020-04-01) -
Circular RNA F-circSR derived from SLC34A2-ROS1 fusion gene promotes cell migration in non-small cell lung cancer
by: Ke Wu, et al.
Published: (2019-05-01)